Scion Life Sciences is a life sciences venture capital firm committed to meaningfully improving human health through long-term ownership of clinically transformative therapies. Our team of experienced innovators, company-builders and investors is founding and building exceptional biotechnology companies to discover, develop, and commercialize clinically transformational or curative new medicines. We aim to support impactful and sustainable advancements with a strategic and pragmatic approach to investment and innovation.
| Website | https://www.scionlifesciences.com/ |
| Employees | 14 (12 on RocketReach) |
| Address | 220 E 42nd St 37th PH Floor, New York, New York 10017, US |
| Phone | +1 646-443-6606 |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Life Sciences, Venture Capital, Life Science Venture Capital, Biotechnology, Healthcare Investing, Therapeutics, Transformative Therapies, Biotech Investing, Clinical Development, Drug Discovery, Medical Innovation, Biopharma, Pharmaceutical, Clinical Trials, Long-Term Investing, Health Tech, Early Stage Investing, Seed Funding, Series A Investing, Growth Equity |
| Competitors | Thermo Fisher Scientific, MilliporeSigma, Agilent Technologies, Pall Corporation, GE HealthCare, PerkinElmer, Inc., Bio-Rad Laboratories, BD, Fisher Scientific, Lonza +39 more (view full list) |
Looking for a particular Scion Life Sciences employee's phone or email?
Aaron Kantoff is the Co-Founder and Managing Partner of Scion Life Sciences.
12 people are employed at Scion Life Sciences.
Scion Life Sciences is based in New York, New York.